vs
ABVC BIOPHARMA, INC.（ABVC）与ACTELIS NETWORKS INC（ASNS）财务数据对比。点击上方公司名可切换其他公司
ACTELIS NETWORKS INC的季度营收约是ABVC BIOPHARMA, INC.的1.7倍（$1.4M vs $796.0K），ACTELIS NETWORKS INC净利率更高（-184.5% vs -256.6%，领先72.1%），ABVC BIOPHARMA, INC.同比增速更快（104.5% vs 28.6%），过去两年ABVC BIOPHARMA, INC.的营收复合增速更高（1041.5% vs 37.2%）
ABVC生物制药是一家处于临床阶段的生物制药企业，专注于开发肿瘤、眼科、中枢神经系统疾病等领域的创新治疗方案，业务覆盖北美及亚洲主要市场，多款自研候选药物正处于临床试验推进阶段。
Actelis Networks Inc是一家专注于宽带接入网络解决方案研发与生产的科技企业，核心产品为可依托现有铜缆基础设施提供高速网络连接的以太网传输系统，客户覆盖电信运营商、企业及政府机构，核心市场分布于北美、欧洲及亚太地区。
ABVC vs ASNS — 直观对比
营收规模更大
ASNS
是对方的1.7倍
$796.0K
营收增速更快
ABVC
高出75.8%
28.6%
净利率更高
ASNS
高出72.1%
-256.6%
两年增速更快
ABVC
近两年复合增速
37.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $796.0K | $1.4M |
| 净利润 | $-2.0M | $-2.5M |
| 毛利率 | 100.0% | 35.1% |
| 营业利润率 | -246.8% | -122.3% |
| 净利率 | -256.6% | -184.5% |
| 营收同比 | 104.5% | 28.6% |
| 净利润同比 | -417.4% | -40.1% |
| 每股收益（稀释后） | $-0.09 | $-5.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABVCASNS
| Q4 25 | — | $1.4M | ||
| Q3 25 | $796.0K | $643.0K | ||
| Q2 25 | — | $941.0K | ||
| Q1 25 | — | $721.0K | ||
| Q4 24 | $2.0K | $1.1M | ||
| Q3 24 | $389.3K | $2.5M | ||
| Q2 24 | $117.1K | $3.4M | ||
| Q1 24 | $1.2K | $726.0K |
净利润ABVCASNS
| Q4 25 | — | $-2.5M | ||
| Q3 25 | $-2.0M | $-2.0M | ||
| Q2 25 | — | $-1.9M | ||
| Q1 25 | — | $-1.9M | ||
| Q4 24 | — | $-1.8M | ||
| Q3 24 | $-394.8K | $-511.0K | ||
| Q2 24 | $-942.3K | $-78.0K | ||
| Q1 24 | $-2.8M | $-2.0M |
毛利率ABVCASNS
| Q4 25 | — | 35.1% | ||
| Q3 25 | 100.0% | 28.5% | ||
| Q2 25 | — | 32.4% | ||
| Q1 25 | — | 34.8% | ||
| Q4 24 | 100.0% | 34.3% | ||
| Q3 24 | 99.9% | 68.6% | ||
| Q2 24 | 99.8% | 56.6% | ||
| Q1 24 | 77.0% | 30.3% |
营业利润率ABVCASNS
| Q4 25 | — | -122.3% | ||
| Q3 25 | -246.8% | -300.0% | ||
| Q2 25 | — | -188.4% | ||
| Q1 25 | — | -251.3% | ||
| Q4 24 | — | -154.0% | ||
| Q3 24 | -77.7% | -12.5% | ||
| Q2 24 | -734.2% | 1.9% | ||
| Q1 24 | -235539.8% | -257.7% |
净利率ABVCASNS
| Q4 25 | — | -184.5% | ||
| Q3 25 | -256.6% | -307.9% | ||
| Q2 25 | — | -202.0% | ||
| Q1 25 | — | -258.0% | ||
| Q4 24 | — | -169.4% | ||
| Q3 24 | -101.4% | -20.1% | ||
| Q2 24 | -804.4% | -2.3% | ||
| Q1 24 | -235203.2% | -273.6% |
每股收益（稀释后）ABVCASNS
| Q4 25 | — | $-5.08 | ||
| Q3 25 | $-0.09 | $-0.17 | ||
| Q2 25 | — | $-0.21 | ||
| Q1 25 | — | $-0.22 | ||
| Q4 24 | — | $-7.90 | ||
| Q3 24 | $-0.03 | $-0.09 | ||
| Q2 24 | $-0.08 | $-0.01 | ||
| Q1 24 | $-0.29 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $257.2K | $4.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $12.1M | $4.8M |
| 总资产 | $21.2M | $9.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABVCASNS
| Q4 25 | — | $4.1M | ||
| Q3 25 | $257.2K | $1.5M | ||
| Q2 25 | — | $393.0K | ||
| Q1 25 | — | $1.1M | ||
| Q4 24 | $313.1K | $2.0M | ||
| Q3 24 | $208.2K | $2.2M | ||
| Q2 24 | $200.0K | $2.4M | ||
| Q1 24 | $106.4K | $1.4M |
总债务ABVCASNS
| Q4 25 | — | — | ||
| Q3 25 | — | $150.0K | ||
| Q2 25 | — | $150.0K | ||
| Q1 25 | — | $150.0K | ||
| Q4 24 | — | $150.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $148.0K |
股东权益ABVCASNS
| Q4 25 | — | $4.8M | ||
| Q3 25 | $12.1M | $3.0M | ||
| Q2 25 | — | $1.3M | ||
| Q1 25 | — | $2.6M | ||
| Q4 24 | $1.2M | $3.0M | ||
| Q3 24 | $1.6M | $3.1M | ||
| Q2 24 | $1.8M | $1.1M | ||
| Q1 24 | $1.7M | $-1.7M |
总资产ABVCASNS
| Q4 25 | — | $9.5M | ||
| Q3 25 | $21.2M | $6.9M | ||
| Q2 25 | — | $6.0M | ||
| Q1 25 | — | $7.1M | ||
| Q4 24 | $7.5M | $8.2M | ||
| Q3 24 | $7.8M | $8.8M | ||
| Q2 24 | $8.0M | $8.4M | ||
| Q1 24 | $8.0M | $10.5M |
负债/权益比ABVCASNS
| Q4 25 | — | — | ||
| Q3 25 | — | 0.05× | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 0.06× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-964.7K | $-2.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ABVCASNS
| Q4 25 | — | $-2.1M | ||
| Q3 25 | $-964.7K | $-2.4M | ||
| Q2 25 | — | $-1.0M | ||
| Q1 25 | — | $-2.2M | ||
| Q4 24 | $-1.8M | $-1.8M | ||
| Q3 24 | $60.2K | $-2.4M | ||
| Q2 24 | $-211.4K | $-2.1M | ||
| Q1 24 | $-955.8K | $-203.0K |
自由现金流ABVCASNS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-204.0K |
自由现金流率ABVCASNS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -28.1% |
资本支出强度ABVCASNS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABVC
暂无分部数据
ASNS
| Europe Middle East And Africa | $1.1M | 83% |
| Other | $228.0K | 17% |
